MIRA INFORM REPORT

 

 

Report Date :

23.01.2014

 

IDENTIFICATION DETAILS

 

Name :

ZIM LABORATORIES LIMITED

 

 

Formerly Known As :

ZIM LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

Flat No. 104, Vivek Co-operative Housing Society, Pipeline Road, Behind Tilak Nagar, Chembur, Mumbai-440089, Maharashtra 

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

14.02.1984

 

 

Com. Reg. No.:

11-032172

 

 

Capital Investment / Paid-up Capital :

Rs.79.985 Millions

 

 

CIN No.:

[Company Identification No.]

L99999MH1984PLC032172 [Old]

L99999MH1984PLC032172 [New]

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMZ01062F

 

 

PAN No.:

[Permanent Account No.]

AAACZ0200E

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on The Stock Exchanges.

 

 

Line of Business :

Manufacturing of Pharmaceuticals Products.

 

 

No. of Employees :

500 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (48)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 4300000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Exist

 

 

Comments :

Subject is an established company having a satisfactory track record.

 

Profitability of the company seems to be fair. General financial position of the company seems to be sound and healthy.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and condition. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2013

 

Country Name

Previous Rating

(30.06.2013)

Current Rating

(30.09.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

INDIAN ECONOMIC OVERVIEW

 

India’s current account deficit narrowed in the quarter ended September as government measures to curb imports, especially gold, kicked in.  The current account deficit, the excess of a country’s imports of goods and services over exports, narrowed to $ 5.2 billion from $ 21 billion in the year ago period, according to provisional Reserve Bank of India data. Finance Minister P. Chidambaram said the CAD for the year will be less than $ 60 billion or 3 per cent of GDP and the latest data suggests the government may achieve the target.

 

India was ranked 94th among the world’s most corrupt nations list. Denmark and New Zealand topped as the cleanest while Somalia emerged as the most corrupt.

 

India’s services sector activity witnessed a moderate improvement in November over the previous month, even while indicating the fifth successive monthly contraction, according the HSBC survey.

 

$53 million estimated losses suffered by India due to phishing attacks during the third quarter, according to a study by RSA. India ranks fourth in the list of nations hit by phishing attacks. The US remained at the top of the charts. Phishing is the process of acquiring information such as user names, passwords and credit card details by sending e-mails disguised as official mails.

 

Rs.4080 million worth of mobile-phone-based transactions by July 2013 compared to Rs.260 million in September, 2012, according to Deloitte report. The number of transactions has shot up from 94000 to 701000.

 

India aims to earn Rs.400000 million from the bandwidth auction set for January. The merger and acquisition guidelines, cleared by a group of ministers, will be out before the auction begins so that players can make informed decisions on the auctions.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating: BBB

Rating Explanation

Moderate degree at safety and moderate credit risk.

Date

15.01.2013

 

Rating Agency Name

CRISIL

Rating

Short term rating: A3+

Rating Explanation

Moderate degree at safety and high credit risk.

Date

15.01.2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Mukesh Kabra

Designation :

Accounts Executive

Contact No.:

91-7118-271370

Date :

21.01.2014

 

 

LOCATIONS

 

Registered Office :

Flat No. 104, Vivek Co-operative Housing Society, Pipeline Road, Behind Tilak Nagar, Chembur, Mumbai-440089, Maharashtra, India

Tel. No.:

91-22-25230284

Fax No.:

Not Available

E-Mail :

anwarsdaud@gmail.com

zimltd@sancharnet.in

alihatim@rediffmail.com

mukesh_kbr@yahoo.co.in

cs@zimlab.in

Website :

www.zimlabs.com

Location:

Owned

 

 

Administrative/ Corporate Office :

Universal Square, 545, Post Box, 320, Shantinagar, Nagpur-440002, Maharashtra, India

Tel. No.:

91-712-2760807/2764597 / 2760307/2770959

Fax No.:

91-712-2763212 / 2770757

E-Mail :

zim@tom2.vsnl.net.in/zimaccts@nagpur.dot.net.in

calhem@nagpur.dot.net.in

calhem_ngp@sancharnet.in

 

 

Factory 1 :

Plot No. B-21/22, MIDC Industrial Area, Kalmeshwar, District Nagpur-441501, Maharashtra, India

Tel. No.:

91-7118-271370/ 271990/ 271480 / 8271470

Fax No.:

91-7118-271470/ 271780/ 440002

E-Mail :

calhem_ngp@sancharnet.in

Area :

1.5 Acer

Location :

Leased

 

 

DIRECTORS

 

As on 28.09.2013

 

Name :

Mr. Anwar Siraj Daud

Designation :

Managing Director

Address :

Daud Compound, Shanti Nagar, Nagpur-440002, Maharashtra, India

Date of Birth/Age :

31.12.1958

Date of Appointment :

01.08.2012

Din No.:

00023529

Pan No.:

ABHPD8385K

 

 

Name :

Mr. Zulfiquar Murtaza Kamal

Designation :

Whole-time director

Address :

MA-8, MIG Colony, Laxmi Nagar, Nagpur – 440022, Maharashtra, India

Date of Birth/Age :

27.08.1960

Date of Appointment :

19.10.2012

Din No.:

01786763

Pan No.:

AASPK1812E

 

 

Name :

Mr. Riyaz Ahmed Kikabhai Kamal

Designation :

Whole Time Director

Address :

67/D, Near MSEB Substation, Shantinagar, Nagpur-440002, Maharashtra, India

Date of Birth/Age :

19.05.1951

Date of Appointment :

01.04.2009

Din No.:

00023562

 

 

Name :

Mr. Suprakash Shivamoy Chakravarty

Designation :

Director

Address :

1101, Caviana – A, Hiranandani Estate, Ghodbunder Road, Thane – 400607, Maharashtra, India

Date of Birth/Age :

23.06.1949

Date of Appointment :

19.10.2012

Din No.:

03010382

 

 

Name :

Mr. Naresh Janardhan Gaikwad

Designation :

Director

Address :

A2-104, Mathda Colony, Amravati Road, Nagpur-440001, Maharashtra, India

Date of Birth/Age :

22.12.1954

Date of Appointment :

28.09.2012

Din No.:

02185462

 

 

Name :

Mr. Veerendra Kumar Parashar

Designation :

Director

Address :

13-P, Bharat Nagar, Nagpur-440033, Maharashtra, India

Date of Birth/Age :

04.11.1940

Date of Appointment :

30.09.2011

Din No.:

02456416

 

 

Name :

Mr. Rahul Deshpande

Designation :

Nominee director

Address :

B-701, Sprint Time Cooperative Housing Society, 3rd Road, off Golibar Road, Santacruz (East), Mumbai – 400055, Maharashtra, India

Date of Birth/Age :

02.06.1976

Date of Appointment :

19.10.2012

Din No.:

03644514

 

 

KEY EXECUTIVES

 

Name :

Rishinaradamangalam Anantharaman Parasuraman

Designation :

Secretary

Address :

Flat No. 6, Atrey Apartment, 6, Buty Plots, Dharampeth, Nagpur-440010, Maharashtra, India

Date of Birth/Age :

02.11.1936

Date of Appointment :

01.02.2008

Pan No.:

AGWPP7486K

 

 

Name :

Mr. Mukesh Kabra

Designation :

Accounts Executive

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 28.09.2013

 

SHAREHOLDING DETAIL FILE ATTACHED

 

Equity Share Break up (Percentage of Total Equity)

 

As on 28.09.2013

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

27.64

Bodies corporate

16.45

Directors or relatives of Directors

45.09

Other top fifty shareholders

5.25

Other

5.57

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of Pharmaceuticals Products.

 

 

Products :

Item Code No.

Product Description

30042064

Azithromycin Tablets IP 500mg

29419090

Azithromycin for Oral Suspension8gm

30045020

Folron Capsules (SR Capsules of Fer)

 

 

Exports :

 

Products :

Finished Goods

Countries :

·         Algeria

·         Sri Lanka

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

L/C and Credit

 

 

Purchasing :

L/C and Credit

 

PRODUCTION STATUS [AS ON 31.03.2011]

 

Particulars

Unit

Installed Capacity

Actual Production

Tablets

Nos.

17149.80

30320.884

Capsules

Nos.

5670.00

3689.071

Pellets

KG

4.07

4.428

Dry Syrup

LTR

0.03

0.004

 

 

GENERAL INFORMATION

 

Customers :

End Users

 

 

No. of Employees :

500 (Approximately)

 

 

Bankers :

·         ICICI Bank Limited, Landmarkrace Cource Circle, Alkapuri, Baroda - 390015, Gujarat, India

·         Bank of India, Nagpur Mid-Corporate Branch, S V Patel Marg,, Nagpur - 440001, Maharashtra, India

·         State Bank of India ( Lead Bank of Consortium), Commercial Branch (Advances), N.G.N Vaidya Marg, Bank Street, Horniman Circle, Post Box10141, Mumbai - 400001, Maharashtra, India

·         The Shamrao Vithal Co-Operative Bank Limited, Yamuna Sadan, Saki Vihar Road, Sakinaka, Andheri (East), Mumbai - 400072, Maharashtra, India

 

 

Facilities :

Secured Loan

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

Long-term Borrowings

 

 

Rupee term loans from banks

17.371

38.642

Foreign currency term loans from banks

156.877

94.202

Short-term borrowings

 

 

Other loans and advances

367.158

357.723

Total

541.406

490.567

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S.R. Batliboi and Company

Chartered Accountants

Address :

14th Floor, The Ruby 29 Senapati Bapat Marg, Dadar (West ), Mumbai-400028, Maharashtra, India

PAN N Income-tax PAN of auditor or auditor's firm :

ACHFS9180N

 

 

Entities where key managerial personnel have significant influence:

Unijules Life Sciences Limited, India [U52311MH2006PLC158928]

 

 

CAPITAL STRUCTURE

 

As on 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

11000000

Equity Shares

Rs.10/- each

Rs. 110.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

7998520

Equity Shares

Rs.10/- each

Rs. 79.985 Millions

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

79.985

60.000

60.000

(b) Reserves & Surplus

988.168

426.108

268.600

(c) Money received against share warrants

0.000

0.000

0.000

 

                      

 

 

(2) Share Application money pending allotment

0.000

41.703

0.000

Total Shareholders’ Funds (1) + (2)

1068.153

527.811

328.600

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

184.885

145.246

54.079

(b) Deferred tax liabilities (Net)

35.685

37.231

26.098

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

2.433

0.000

0.000

Total Non-current Liabilities (3)

223.003

182.477

80.177

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

380.494

376.885

340.821

(b) Trade payables

326.129

280.302

247.928

(c) Other current liabilities

115.645

125.347

175.048

(d) Short-term provisions

69.717

60.549

36.325

Total Current Liabilities (4)

891.985

843.083

800.122

 

 

 

 

TOTAL

2183.141

1553.371

1208.899

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

434.873

403.030

329.746

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

232.946

52.711

21.098

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.510

0.529

10.512

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

27.814

23.031

9.294

(e) Other Non-current assets

3.163

16.525

0.000

Total Non-Current Assets

699.306

495.826

370.650

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

236.210

140.037

165.275

(c) Trade receivables

773.525

590.856

451.035

(d) Cash and cash equivalents

239.309

117.862

61.105

(e) Short-term loans and advances

232.237

208.459

160.834

(f) Other current assets

2.554

0.331

0.000

Total Current Assets

1483.835

1057.545

838.249

 

 

 

 

TOTAL

2183.141

1553.371

1208.899

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

1850.037

1826.572

1408.974

 

 

Other Income

34.940

39.705

20.922

 

 

TOTAL                                     (A)

1884.977

1866.277

1429.896

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

985.745

1059.775

882.600

 

 

Purchases of stock-in-trade

235.389

15.840

15.057

 

 

Changes in inventories of finished goods, work-in-progress and

stock-in-trade

(73.996)

23.842

(32.280)

 

 

Employee benefit expense

128.666

112.273

86.324

 

 

Other expenses

311.556

319.493

261.112

 

 

TOTAL                                     (B)

1587.360

1531.223

1212.813

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

297.617

335.054

217.083

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

89.035

76.605

62.089

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

208.582

258.449

154.994

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

30.616

23.555

17.691

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

177.966

234.894

137.303

 

 

 

 

 

Less

TAX                                                                  (H)

82.725

70.413

42.468

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

95.241

164.481

94.835

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

416.404

263.096

175.258

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

2.381

4.200

0.000

 

 

Proposed Dividend

7.999

6.000

6.000

 

 

Tax on Dividend

1.298

0.973

0.996

 

BALANCE CARRIED TO THE B/S

499.967

416.404

263.097

 

 

 

 

 

 

Earnings Per Share (Rs.)

13.82

27.41

15.81

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

5.53

8.81

6.63

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

9.62

12.86

9.63

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

9.13

15.66

11.66

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.17

0.45

0.42

0

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.53

0.99

1.20

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.66

1.25

1.05

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

--

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

LITIGATION DETAILS

CASE DETAILS

BENCH:-BOMBAY

 

 

Lodging No.:-

LPETNL/15/2009

Filing Date:-

27/01/2009

Reg. No.:-

LPETN/15/2009

Reg. Date:-

27/01/2009

 

 

 

 

Petitioner:-

AJANTA PHARMA LIMITED

Respondent:-

ZIM LABORATORIES LIMITED

 

 

 

Petn.Adv.:-

MAHESH A MAHADGUT (0)

 

 

 

District:-

Bombay

 

 

 

 

Bench:-

SINGLE

 

 

 

 

Status:-

Pre-Admission

Category:-

LEAVE PETITION UNDER CLAUSE XIV

 

 


NOTE:

 

The registered office of the company has been shifted from 41, Manisha Plaza, Ground Floor, Sonapur Lane, Off. LBS Marg, Kurla (West), Mumbai – 400 070, Maharashtra, India to the present address w.e.f. 01.01.2013.

 

WORKING RESULTS:-

 

The Net sales for the financial year were Rs. 1850.037 Millions as against Rs. 1826.572 Millions for the previous financial year registering an increase of 1.28 % over the previous year. The profit before tax has decreased from Rs.234.894 Millions to Rs. 154.926 Millions during the year.

 

PRESENT OUTLOOK:

 

Continued to post satisfactory progress in all its business areas. The enhancement of capacity at existing plant site is at final stage of completion and a new cephalosporin formulation unit was commissioned. The company realizing that it could tap the great institutional market opportunity available by increasing its penetration, decided to create its own institutional marketing team, initiating recruitments for creating specialized division to address the market on its own.

 

PROJECTION:

 

The Iranian market development efforts started yielding result along with those in Cuba, Congo and Ecuador by March end. The pending orders in these new territories exceeded 100.000 Millions. These emerging markets along with Kenya and Yemen, where the company has been approved after successful MOH audits are expected to give enhanced growth by leveraging Company’s existing products in wider geography.

 

Also having developed the Oral Thin film technology and finding it to be an exciting technology for growing its existing and future markets steps were initiated to fast track the building of a small OTF manufacturing facilities.

 

The OTF facility is under construction and timed for July 13 completion and five products applications have been submitted to DCG for approval.

 

UNSECURED LOAN

 

PARTICULARS

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

Long-term Borrowings

 

 

Borrowing from government

semi-government bodies

5.500

3.000

Deferred sales tax loan

5.137

5.137

Loans repayable on demand from others

0.000

4.265

Short-term borrowings

 

 

Loans and advances from others

13.336

0.000

Other loans and advances [

0.000

19.162

Total

23.973

31.564

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10456796

17/10/2013

170,000,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA, GUJARAT - 390015, INDIA

B88214192

2

10412179

27/02/2013 *

670,600,000.00

BANK OF INDIA

NAGPUR MID-CORPORATE BRANCH, S V PATEL MARG, NA
GPUR, MAHARASHTRA - 440001, INDIA

B71677348

3

10335637

17/01/2012

160,200,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA, GUJARAT - 390015, INDIA

B32159568

4

10237019

12/03/2008

238,500,000.00

THE SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED

YAMUNA SADAN, SAKI VIHAR ROAD, SAKINAKA, ANDHERI (EAST), MUMBAI, MAHARASHTRA - 400072, INDIA

A51231785

5

10237012

30/10/2007

146,000,000.00

THE SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED

YAMUNA SADAN, SAKI VIHAR ROAD, SAKINAKA, ANDHERI
(EAST), MUMBAI, MAHARASHTRA - 400072, INDIA

A51231447

6

10233822

20/10/2007

123,500,000.00

THE SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED

YAMUNA SADAN, SAKI VIHAR ROAD, SAKINAKA, ANDHERI
(EAST), MUMBAI, MAHARASHTRA - 400072, INDIA

A51225753

 

* Date of charge modification

 

FIXED ASSETS

 

Tangible assets

 

·         Land

·         Buildings

·         Plant and equipment

·         Office equipment

·         Vehicles

·         Plantations


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.92

UK Pound

1

Rs.101.98

Euro

1

Rs.83.93

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLK

 

 

Report Prepared by :

KVT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

9

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

48

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.